Electronic cigarette use among Italian smokers: patterns, settings, and adverse events.

E-cigarettes Italy adverse events patterns of use survey

Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
26 Apr 2020
Historique:
entrez: 28 4 2020
pubmed: 28 4 2020
medline: 28 4 2020
Statut: aheadofprint

Résumé

Information is scanty on the patterns and settings of electronic cigarette use and on its possible adverse events. To fill the knowledge gap on these issues, we conducted a survey among ever-smokers attending smoking cessation services (SCS) in Italy. In 2016-2018, we enrolled 395 ever-smokers aged ⩾18 years who were current or former electronic cigarette users in 12 SCS from northern, central, and southern Italy. In all, 12.4% of ever smokers were regular, 9.4% occasional, and 78.2% past users of electronic cigarettes. Of all users, 93.8% consumed electronic cigarettes with nicotine, 95.9% used refillable devices, and 76.6% purchased electronic cigarette devices or liquids in vape shops. The mean duration of use was 3.7 months and the mean number of puffs per day was 86. Among users, 71.5% used electronic cigarettes in at least 1 smoke-free indoor environment, 53.7% in workplaces, 49.5% in restaurants and bars, 33.5% in train/metro stations or airports, and 18.4% in public transports. The use of electronic cigarettes in smoke-free environments significantly decreased with age and increased with duration of use and nicotine dependence. In our sample, 47.1% reported at least 1 adverse event attributable to electronic cigarette use: 19.5% dry cough, 12.0% dry mouth, 7.6% throat or mouth irritation, and 6.8% sore throat. In Italy, most conventional cigarette smokers use electronic cigarettes where smoking conventional cigarettes is prohibited. About half of users reported 1 or more symptoms attributable to electronic cigarettes, despite the relatively short duration of use.

Identifiants

pubmed: 32338200
doi: 10.1177/0300891620915784
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

300891620915784

Auteurs

Silvano Gallus (S)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Elisa Borroni (E)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Xiaoqiu Liu (X)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Laura Carrozzi (L)

Pulmonary Unit, Cardiothoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy.

Gianfranco Dalla Pietra (G)

Department of Pneumology, Santa Maria della Misericordia Hospital, Rovigo, Italy.

Shokoofe Eslami Varzaneh (S)

Department of Pneumology, San Camillo De Lellis Hospital, Rieti, Italy.

Sergio Harari (S)

Department of Medical Sciences and Division of Pneumology, San Giuseppe Hospital, IRCCS MultiMedica, Milan, Italy.

Giovanni Inciso (G)

Unit of Pneumology, ASL Na 3 (Sanitary District 59), Meta di Sorrento, NA, Italy.

Paola Martucci (P)

Unit of Interventional Pneumology, Azienda Ospedaliera di Rilievo Nazionale "Antonio Cardarelli", Naples, Italy.

Maria Papale (M)

Department of Respiratory Physiopathology, Regina Elena Institute IRCCS, Rome, Italy.

Francesco Pistelli (F)

Pulmonary Unit, Cardiothoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy.

Biagio Polla (B)

Department of Respiratory System Diseases, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo, Alessandria, Italy.

Maria Francesca Polo (MF)

Department of Pneumology, Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy.

Rosastella Principe (R)

Smoking Cessation Center, S. Camillo-Forlanini Hospital, Rome, Italy.

Nolita Pulerà (N)

Department of Pneumology, P.O. di Livorno-AUSL Toscana Nord Ovest, Livorno, Italy.

Stefania Raschi (S)

Department of Pneumology, ASST Vimercate, Vimercate, MB, Italy.

Riccardo Sarzani (R)

Internal Medicine and Geriatrics, IRCCS-INRCA, Ancona, Italy.

Antonella Serafini (A)

Department of Pneumology, Imperia Hospital, Imperia, Italy.

Anna Odone (A)

School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

Piet van den Brandt (P)

Department of Epidemiology, CAPHRI-School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.

Alessandra Lugo (A)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Classifications MeSH